FindMyKOL
Clinical trialNCT04606264CompletedPhase 3Interventional

Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data

SponsorJennifer Holder-MurrayEnrollment3,395Perioperative Optimization
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This REMAP Periop ERP domain study falls under the Periop Core Protocol, which compares the different recommended strategies for enhancing recovery through the use of various standard of care treatments before, during and after surgery in all patients with elective surgical encounters at UPMC who meet eligibility criteria. The ERP domain seeks to enhance recovery by optimizing strategies of perioperative care through evaluating combinations of perioperative treatment, which consists of preoperative, intraoperative and postoperative care. Optimal combinations of perioperative care will be generated and analyzed to determine the best outcomes for patients as defined by reduction in hospital free days, reduction in postoperative nausea and vomiting, and improved pain control.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Upmc Magee-Womens Hospital

    Pittsburgh, Pennsylvania, United States

  • Upmc Passavant

    Pittsburgh, Pennsylvania, United States

  • Upmc Presbyterian

    Pittsburgh, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Aprepitant →Dexamethasone →DimenhydrinateNeuraxial AnalgesiaOndansetron →Perphenazine →Regional Block 1: ParavertebralRegional Block 2: QL1
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 May 2023
Primary completion
21 Mar 2025
Completion
21 Mar 2025
Last update posted
28 May 2026
Registered enrollment
3,395
Registry id
NCT04606264
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.